Table 1.
Overview of clinical trials in diagnosis.
| Characteristics | Number | Percentage (%) |
|---|---|---|
| Liver diseases | ||
| Hepatic B/C with/without liver failure or liver fibroses | 3 | 15.00 |
| NAFLD/alcoholic fatty liver with/without liver fibroses | 4 | 20.00 |
| Liver cirrhosis | 1 | 5.00 |
| Liver cancer/HCC | 8 | 40.00 |
| Polycystic liver disease | 1 | 5.00 |
| Liver metastases | 1 | 5.00 |
| Focal liver lesions | 2 | 10.00 |
| Application method | ||
| Imaging | 9 | 45.00 |
| Pathology/biopsy | 2 | 10.00 |
| Biomarker/lab test | 4 | 20.00 |
| Imaging and biomarker/lab test | 1 | 5.00 |
| Other | 4 | 20.00 |